HSP27 modulates survival signaling networks in cells treated with curcumin and TRAIL

Cellular Signalling

Volumn 24, Issue 7, 2012, Pages 1444-1452

  Kim, Jina ^a   Kim, So Y ^a   Kang, Sujin ^a   Yoon, Hyo R ^a   Sun, Bo K ^a   Kang, Dongxu ^a   Kim, Joo Hang ^a   Song, Jae J ^a  

^a Yonsei University   (South Korea)

Author keywords

Akt; Curcumin; HSP27; PDK1; PP1; Src; TRAIL

Indexed keywords

CURCUMIN; HEAT SHOCK PROTEIN 27; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN KINASE B; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ARTICLE; CANCER CELL; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TREATMENT RESPONSE;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; DRUG SYNERGISM; HSP27 HEAT-SHOCK PROTEINS; HUMANS; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, NEUROPEPTIDE Y; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84859937800     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2012.03.009     Document Type: Article

References (55)

1. Kim M.J., Choi S.Y., Park I.C., Hwang S.G., Kim C., Choi Y.H., Kim H., Lee K.H., Lee S.J. Molecular Cancer Research 2008, 6:1718-1731.
2. Weldon C.B., Parker A.P., Patten D., Elliott S., Tang Y., Frigo D.E., Dugan C.M., Coakley E.L., Butler N.N., Clayton J.L., Alam J., Curiel T.J., Beckman B.S., Jaffe B.M., Burow M.E. International Journal of Oncology 2004, 24:1473-1480.
3. Matsuzawa A., Ichijo H. Journal of Biochemistry 2001, 130:1-8.
4. Leppa S., Bohmann D. Oncogene 1999, 18:6158-6162.
5. Liu J., Lin A. Cell Research 2005, 15:36-42.
6. Roulston A., Reinhard C., Amiri P., Williams L.T. Journal of Biological Chemistry 1998, 273:10232-10239.
7. Luo Y., DeFranco D.B. Journal of Biological Chemistry 2006, 281:16436-16442.
8. Almasan A., Ashkenazi A. Cytokine & Growth Factor Reviews 2003, 14:337-348.
9. Wu G.S. Cancer Letters 2009, 285:1-5.
10. Zhu H., Zhang L., Huang X., Davis J.J., Jacob D.A., Teraishi F., Chiao P., Fang B. Molecular Therapy 2004, 9:666-673.
11. Ishimura N., Isomoto H., Bronk S.F., Gores G.J. American Journal of Physiology. Gastrointestinal and Liver Physiology 2006, 290:G129-G136.
12. Trauzold A., Siegmund D., Schniewind B., Sipos B., Egberts J., Zorenkov D., Emme D., Roder C., Kalthoff H., Wajant H. Oncogene 2006, 25:7434-7439.
13. Song J.J., Szczepanski M.J., Kim S.Y., Kim J.H., An J.Y., Kwon Y.T., Alcala M.A., Bartlett D.L., Lee Y.J. Cellular Signalling 2010, 22:553-563.
14. Sun B.K., Kim J.H., Nguyen H.N., Kim S.Y., Oh S., Lee Y.J., Song J.J. International Journal of Oncology 2011, 38:249-256.
15. Deeb D., Jiang H., Gao X., Hafner M.S., Wong H., Divine G., Chapman R.A., Dulchavsky S.A., Gautam S.C. Molecular Cancer Therapeutics 2004, 3:803-812.
16. Deeb D., Jiang H., Gao X., Al-Holou S., Danyluk A.L., Dulchavsky S.A., Gautam S.C. Journal of Pharmacology and Experimental Therapeutics 2007, 321:616-625.
17. Mukhopadhyay A., Bueso-Ramos C., Chatterjee D., Pantazis P., Aggarwal B.B. Oncogene 2001, 20:7597-7609.
18. Weir N.M., Selvendiran K., Kutala V.K., Tong L., Vishwanath S., Rajaram M., Tridandapani S., Anant S., Kuppusamy P. Cancer Biology & Therapy 2007, 6:178-184.
19. Hatcher H., Planalp R., Cho J., Torti F.M., Torti S.V. Cellular and Molecular Life Sciences 2008, 65:1631-1652.
20. Aggarwal B.B., Sundaram C., Malani N., Ichikawa H. Advances in Experimental Medicine and Biology 2007, 595:1-75.
21. Aggarwal B.B., Kumar A., Bharti A.C. Anticancer Research 2003, 23:363-398.
22. Plummer S.M., Hill K.A., Festing M.F., Steward W.P., Gescher A.J., Sharma R.A. Cancer Epidemiology, Biomarkers & Prevention 2001, 10:1295-1299.
23. Hour T.C., Chen J., Huang C.Y., Guan J.Y., Lu S.H., Pu Y.S. Prostate 2002, 51:211-218.
24. Chuang S.E., Yeh P.Y., Lu Y.S., Lai G.M., Liao C.M., Gao M., Cheng A.L. Biochemical Pharmacology 2002, 63:1709-1716.
25. Harbottle A., Daly A.K., Atherton K., Campbell F.C. International Journal of Cancer 2001, 92:777-783.
26. Dhandapani K.M., Mahesh V.B., Brann D.W. Journal of Neurochemistry 2007, 102:522-538.
27. Bharti A.C., Donato N., Singh S., Aggarwal B.B. Blood 2003, 101:1053-1062.
28. Jung E.M., Lim J.H., Lee T.J., Park J.W., Choi K.S., Kwon T.K. Carcinogenesis 2005, 26:1905-1913.
29. Ramsewak R.S., DeWitt D.L., Nair M.G. Phytomedicine 2000, 7:303-308.
30. Leu T.H., Maa M.C. Current Medicinal Chemistry. Anti-Cancer Agents 2002, 2:357-370.
31. Balasubramanyam M., Koteswari A.A., Kumar R.S., Monickaraj S.F., Maheswari J.U., Mohan V. Journal of Biosciences 2003, 28:715-721.
32. Kundu J.K., Surh Y.J. Mutation Research 2004, 555:65-80.
33. Singh S., Aggarwal B.B. Journal of Biological Chemistry 1995, 270:24995-25000.
34. Surh Y.J. Nature Reviews. Cancer 2003, 3:768-780.
35. Singh S., Khar A. Anti-Cancer Agents in Medicinal Chemistry 2006, 6:259-270.
36. Bae M.K., Kim S.H., Jeong J.W., Lee Y.M., Kim H.S., Kim S.R., Yun I., Bae S.K., Kim K.W. Oncology Reports 2006, 15:1557-1562.
37. Yoysungnoen P., Wirachwong P., Bhattarakosol P., Niimi H., Patumraj S. Clinical Hemorheology and Microcirculation 2006, 34:109-115.
38. Lin Y.G., Kunnumakkara A.B., Nair A., Merritt W.M., Han L.Y., Armaiz-Pena G.N., Kamat A.A., Spannuth W.A., Gershenson D.M., Lutgendorf S.K., Aggarwal B.B., Sood A.K. Clinical Cancer Research 2007, 13:3423-3430.
39. Gao X., Deeb D., Jiang H., Liu Y.B., Dulchavsky S.A., Gautam S.C. Journal of Experimental Therapeutics and Oncology 2005, 5:39-48.
40. Shankar S., Ganapathy S., Chen Q., Srivastava R.K. Molecular Cancer 2008, 7:16.
41. Shankar S., Chen Q., Sarva K., Siddiqui I., Srivastava R.K. Journal of Molecular Signaling 2007, 2:10.
42. Cao Z., Xiong J., Takeuchi M., Kurama T., Goeddel D.V. Nature 1996, 383:443-446.
43. Song J.J., Kim J.-H., Sun B.K., Alcala M.A., Bartlett D.L., Lee Y.J. Cellular Signalling 2010, 22:377-385.
44. Thayyullathil F., Chathoth S., Shahin A., Kizhakkayil J., Hago A., Patel M., Galadari S. Journal of Cellular Biochemistry 2011, 112:1138-1153.
45. Qian J., Vafiadaki E., Florea S.M., Singh V.P., Song W., Lam C.K., Wang Y., Yuan Q., Pritchard T.J., Cai W., Haghighi K., Rodriguez P., Wang H.S., Sanoudou D., Fan G.C., Kranias E.G. Circulation Research 2011, 108:1429-1438.
46. Wong B.R., Besser D., Kim N., Arron J.R., Vologodskaia M., Hanafusa H., Choi Y. Molecular Cell 1999, 4:1041-1049.
47. Schlessinger J. Cell 2000, 100:293-296.
48. Havasi A., Wang Z., Gall J.M., Spaderna M., Suri V., Canlas E., Martin J.L., Schwartz J.H., Borkan S.C. American Journal of Physiology. Renal Physiology 2009, 297:F760-F768.
49. Kamada M., So A., Muramaki M., Rocchi P., Beraldi E., Gleave M. Molecular Cancer Therapeutics 2007, 6:299-308.
50. Song H., Ethier S.P., Dziubinski M.L., Lin J. Biochemical and Biophysical Research Communications 2004, 143-150.
51. Nakashima M., Adachi S., Yasuda I., Yamauchi T., Kawaguchi J., Itani M., Yoshioka T., Matsushima-Nishiwaki R., Hirose Y., Kozawa O., Moriwaki H. Cancer Letters 2011, 313:218-225.
52. Kim S.J., Son T.G., Park H.R., Park M., Kim M.S., Kim H.S., Chung H.Y., Mattson M.P., Lee J. The Journal of Biological Chemistry 2008, 283:14497-14505.
53. Gescher A.J., Sharma R.A., Steward W.P. The Lancet Oncology 2001, 2:371-379.
54. Somasundaram S., Edmund N.A., Moore D.T., Small G.W., Shi Y.Y., Orlowski R.Z. Cancer Research 2002, 62:3868-3875.
55. Shishodia S., Aggarwal B.B. Journal of Biochemistry and Molecular Biology 2002, 35:28-40.